Scope of the Report:

The worldwide market for Natural Killer Cell Therapies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.

This report focuses on the Natural Killer Cell Therapies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Nektar Therapeutics

Kiadis Pharma

Chipscreen Biosciences

Innate

Dragonfly Therapeutics

Affimed

Nkarta Therapeutics

Glycostem

Fate Therapeutics

NantWorks

Fortress Biotech

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

NK Cell Therapies

NK Cell Directed Antibodies

Market Segment by Applications, can be divided into

Cancer

Gastrointestinal Diseases

Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Natural Killer Cell Therapies product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Natural Killer Cell Therapies, with price, sales, revenue and global market share of Natural Killer Cell Therapies in 2017 and 2018.

Chapter 3, the Natural Killer Cell Therapies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Natural Killer Cell Therapies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Natural Killer Cell Therapies market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Natural Killer Cell Therapies sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Natural Killer Cell Therapies Introduction

1.2 Market Analysis by Type

1.2.1 NK Cell Therapies

1.2.2 NK Cell Directed Antibodies

1.3 Market Analysis by Applications

1.3.1 Cancer

1.3.2 Gastrointestinal Diseases

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Nektar Therapeutics

2.1.1 Business Overview

2.1.2 Natural Killer Cell Therapies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Nektar Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Kiadis Pharma

2.2.1 Business Overview

2.2.2 Natural Killer Cell Therapies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Kiadis Pharma Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Chipscreen Biosciences

2.3.1 Business Overview

2.3.2 Natural Killer Cell Therapies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Innate

2.4.1 Business Overview

2.4.2 Natural Killer Cell Therapies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Innate Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Dragonfly Therapeutics

2.5.1 Business Overview

2.5.2 Natural Killer Cell Therapies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Affimed

2.6.1 Business Overview

2.6.2 Natural Killer Cell Therapies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Affimed Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Nkarta Therapeutics

2.7.1 Business Overview

2.7.2 Natural Killer Cell Therapies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Glycostem

2.8.1 Business Overview

2.8.2 Natural Killer Cell Therapies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Glycostem Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Fate Therapeutics

2.9.1 Business Overview

2.9.2 Natural Killer Cell Therapies Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Fate Therapeutics Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 NantWorks

2.10.1 Business Overview

2.10.2 Natural Killer Cell Therapies Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 NantWorks Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Fortress Biotech

2.11.1 Business Overview

2.11.2 Natural Killer Cell Therapies Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Fortress Biotech Natural Killer Cell Therapies Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Natural Killer Cell Therapies Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Natural Killer Cell Therapies Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Natural Killer Cell Therapies Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Natural Killer Cell Therapies Manufacturer Market Share in 2018

3.3.2 Top 6 Natural Killer Cell Therapies Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Natural Killer Cell Therapies Market Analysis by Regions

4.1 Global Natural Killer Cell Therapies Sales, Revenue and Market Share by Regions

4.1.1 Global Natural Killer Cell Therapies Sales and Market Share by Regions (2014-2019)

4.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Regions (2014-2019)

4.2 North America Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

4.3 Europe Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

4.5 South America Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

5 North America Natural Killer Cell Therapies by Country

5.1 North America Natural Killer Cell Therapies Sales, Revenue and Market Share by Country

5.1.1 North America Natural Killer Cell Therapies Sales and Market Share by Country (2014-2019)

5.1.2 North America Natural Killer Cell Therapies Revenue and Market Share by Country (2014-2019)

5.2 United States Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

5.3 Canada Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

5.4 Mexico Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

6 Europe Natural Killer Cell Therapies by Country

6.1 Europe Natural Killer Cell Therapies Sales, Revenue and Market Share by Country

6.1.1 Europe Natural Killer Cell Therapies Sales and Market Share by Country (2014-2019)

6.1.2 Europe Natural Killer Cell Therapies Revenue and Market Share by Country (2014-2019)

6.2 Germany Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

6.3 UK Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

6.4 France Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

6.5 Russia Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

6.6 Italy Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

7 Asia-Pacific Natural Killer Cell Therapies by Country

7.1 Asia-Pacific Natural Killer Cell Therapies Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Natural Killer Cell Therapies Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Natural Killer Cell Therapies Revenue and Market Share by Country (2014-2019)

7.2 China Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

7.3 Japan Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

7.4 Korea Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

7.5 India Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

8 South America Natural Killer Cell Therapies by Country

8.1 South America Natural Killer Cell Therapies Sales, Revenue and Market Share by Country

8.1.1 South America Natural Killer Cell Therapies Sales and Market Share by Country (2014-2019)

8.1.2 South America Natural Killer Cell Therapies Revenue and Market Share by Country (2014-2019)

8.2 Brazil Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

8.3 Argentina Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

8.4 Colombia Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

9 Middle East and Africa Natural Killer Cell Therapies by Countries

9.1 Middle East and Africa Natural Killer Cell Therapies Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Natural Killer Cell Therapies Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Natural Killer Cell Therapies Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

9.3 Turkey Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

9.4 Egypt Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

9.5 Nigeria Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

9.6 South Africa Natural Killer Cell Therapies Sales and Growth Rate (2014-2019)

10 Global Natural Killer Cell Therapies Market Segment by Type

10.1 Global Natural Killer Cell Therapies Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Natural Killer Cell Therapies Sales and Market Share by Type (2014-2019)

10.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Type (2014-2019)

10.2 NK Cell Therapies Sales Growth and Price

10.2.1 Global NK Cell Therapies Sales Growth (2014-2019)

10.2.2 Global NK Cell Therapies Price (2014-2019)

10.3 NK Cell Directed Antibodies Sales Growth and Price

10.3.1 Global NK Cell Directed Antibodies Sales Growth (2014-2019)

10.3.2 Global NK Cell Directed Antibodies Price (2014-2019)

11 Global Natural Killer Cell Therapies Market Segment by Application

11.1 Global Natural Killer Cell Therapies Sales Market Share by Application (2014-2019)

11.2 Cancer Sales Growth (2014-2019)

11.3 Gastrointestinal Diseases Sales Growth (2014-2019)

11.4 Others Sales Growth (2014-2019)

12 Natural Killer Cell Therapies Market Forecast (2019-2024)

12.1 Global Natural Killer Cell Therapies Sales, Revenue and Growth Rate (2019-2024)

12.2 Natural Killer Cell Therapies Market Forecast by Regions (2019-2024)

12.2.1 North America Natural Killer Cell Therapies Market Forecast (2019-2024)

12.2.2 Europe Natural Killer Cell Therapies Market Forecast (2019-2024)

12.2.3 Asia-Pacific Natural Killer Cell Therapies Market Forecast (2019-2024)

12.2.4 South America Natural Killer Cell Therapies Market Forecast (2019-2024)

12.2.5 Middle East and Africa Natural Killer Cell Therapies Market Forecast (2019-2024)

12.3 Natural Killer Cell Therapies Market Forecast by Type (2019-2024)

12.3.1 Global Natural Killer Cell Therapies Sales Forecast by Type (2019-2024)

12.3.2 Global Natural Killer Cell Therapies Market Share Forecast by Type (2019-2024)

12.4 Natural Killer Cell Therapies Market Forecast by Application (2019-2024)

12.4.1 Global Natural Killer Cell Therapies Sales Forecast by Application (2019-2024)

12.4.2 Global Natural Killer Cell Therapies Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Natural Killer Cell Therapies Picture

Table Product Specifications of Natural Killer Cell Therapies

Figure Global Sales Market Share of Natural Killer Cell Therapies